News
Waters stellt Xevo TQ Absolute vor – das empfindlichste und kompakteste Tandem-Quadrupol-Massenspektrometer für den Tischeinsatz
Waters Corporation (NYSE:WAT) hat heute das neue System Xevo™ TQ Absolute vorgestellt, das empfindlichste und kompakteste Tandem-Massenspektrometer seiner Klasse für den Tischeinsatz.i
Diese
Dexcom Announces Dexcom ONE, the Newest Real-Time Continuous Glucose Monitoring System, to Its Range of Scan-Free and Fingerprick†-Free Devices
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the new Dexcom ONE Continuous Glucose Monitoring System will
Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer
Waters Corporation (NYSE:WAT) today introduced the new Xevo™ TQ Absolute system, the most sensitive and compact benchtop tandem mass spec in its class.i
This press release features multimedia
STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that the U.S. Food and Drug
Waters präsentiert eine schnellere, zuverlässigere und automatisierte Lösung für die Massen- und Reinheitsanalyse von Biomolekülen
Die Waters Corporation (NYSE:WAT) stellte heute neue Software und analytische Säulen zur Unterstützung der Erforschung und Entwicklung von Biomolekülen vor. Mit der neuen App 'Intact Mass' von
Waters Introduces Faster, Reliable and Automated Solution for Mass and Purity Analysis of Biomolecules
Waters Corporation (NYSE:WAT) today introduced new software and analytical columns to aid biomolecule drug discovery and development. The new Waters™ Intact Mass app on waters_connect™ allows
Dexcom G7 erhält CE-Kennzeichnung – Das kontinuierliche Blutzuckermesssystem der nächsten Generation wird das Diabetesmanagement revolutionieren
DexCom, Inc. (NASDAQ:DXCM), der weltweit führende Anbieter im Bereich der kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, gab heute bekannt, dass das Unternehmen die
Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark (Conformité Européenne) for the Dexcom G7
Ontario Announces Public Coverage for the Dexcom G6 Continuous Glucose Monitoring System under the Assistive Devices Program
Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM), is pleased to announce that effective March 14 2022, the Ontario government will provide coverage
Humana Launches CenterWell Home Health
One year after launching the CenterWell brand to represent Humana’s payer-agnostic healthcare service offerings, Humana Inc. (NYSE: HUM) has started to transition Kindred at Home’s home health
NanoString to Showcase CosMx Spatial Molecular Imager at 4th Annual Spatial Genomics Summit, Feb. 28
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial unveiling of the CosMx™ Spatial
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company and parent of cancer prevention company Lucid Diagnostics Inc. (Nasdaq:
Humana Earns Top Score in Human Rights Campaign Foundation’s 2022 Corporate Equality Index
Leading health insurer and health care services company Humana Inc. (NYSE: HUM), proudly announced that it received a score of 100 on the Human Rights Campaign Foundation’s 2022 Corporate Equality
Dexcom G6 Continuous Glucose Monitoring System Now Covered in Alberta for Children and Youth Living With Diabetes
Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM), announced today that people with diabetes who are under 18 years old and require ongoing use of
Waters Earns Top Score in Human Rights Campaign Foundation’s 2022 Corporate Equality Index
Waters Corporation (NYSE:WAT) announced that it received a score of 100 on the Human Rights Campaign Foundation’s 2022 Corporate Equality Index (CEI), the nation’s foremost benchmarking survey and
AMN Healthcare CEO Susan Salka Recognized as One of 100 Most Influential People by Modern Healthcare
Susan Salka, Chief Executive Officer of AMN Healthcare, was recognized by Modern Healthcare as one of the 100 Most Influential People in Healthcare for 2021, a year of unprecedented stress for
AMN Healthcare Names Jorge Caballero to Board of Directors
AMN Healthcare (NYSE: AMN) today announced the Board of Directors has appointed Jorge A. Caballero as a new independent director.
This press release features multimedia. View the full release
Humana Foundation Names Tiffany Benjamin As Chief Executive Officer
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) has announced the appointment of Tiffany Benjamin as its new Foundation CEO, effective January 3, 2022.
This press release
AMN Healthcare Board Members Sylvia Trent-Adams and Daphne E. Jones Named to Savoy Magazine’s Most Influential Black Corporate Directors
Two members of the AMN Healthcare Board of Directors – Daphne E. Jones and Sylvia Trent-Adams -- have been named to Savoy Magazine’s prestigious 2021 list of Most Influential Black Corporate
Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
Agilent Technologies Inc. (NYSE: A) has announced that the Agilent Cary 3500 UV-Vis Spectrophotometer is now compatible with the Agilent OpenLab software suite of products. The Cary 3500 UV-Vis
Intuitive Surgical: Absolut überzeugend!
In den USA hat die Berichtssaison bereits begonnen, so dass derzeit ein Unternehmen nach dem anderen seine aktuellen Quartalszahlen vorlegt. Gestern Abend, nachbörslich, war nun der
Eckert & Ziegler: Charttechnik deutet Kursexplosion an!
Ein explosives charttechnisches Setup finden Trader zurzeit bei der Aktie von Eckert & Ziegler (WKN: 565970) vor. Verhält sich die Aktie regelkonform, winkt hier ein Kurssprung!
So konnte die Aktie
Eckert & Ziegler unter Abgabedruck: Die Alternative?!
Die Aktie von Eckert & Ziegler (WKN: 565970) steht heute unter Abgabedruck, nachdem das deutsche Vorzeige-Medizintechnikunternehmen seine aktuellen Quartalszahlen vorgelegt hat. Denn diese fielen
Sartorius: Unternehmen profitiert von der Corona-Krise
Ein absoluter Highflyer am deutschen Aktienmarkt ist schon seit vielen Jahren die Vorzugsaktie des Göttinger Laborausrüsters Sartorius (WKN: 716563). Dies ist umso erstaunlicher, da noch zu Neuer